Cochrane · systematic review · CD004706
Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer
Lawrie, TA, Winter‐Roach, BA, Heus, P, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
4
No studies
1
Included studies
NR
No studies 1 · 20%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 4 · 80%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsSummary of main findings
Population: women with stage I/II epithelial ovarian cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Overall 5‐year survival1 | no estimate extracted | 1008 participants | High |
Progression‐free 5‐year survival2 | no estimate extracted | 1170 participants | High |
Overall 10‐year3 survival | no estimate extracted | 925 participants | High |
Progression‐free 10‐year survival4 | no estimate extracted | 925 participants | High |
Adverse events | no estimate extracted | NR | No studies |